Corcept Therapeutics
CORT
CORT
207 hedge funds and large institutions have $1.26B invested in Corcept Therapeutics in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 86 increasing their positions, 64 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
21% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 34
46% less call options, than puts
Call options by funds: $6.35M | Put options by funds: $11.8M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
207
Holding in Top 10
1
Calls
$6.35M
Puts
$11.8M
Top Buyers
| 1 | +$21.7M | |
| 2 | +$15.2M | |
| 3 | +$13.4M | |
| 4 |
Morgan Stanley
New York
|
+$10M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$6.68M |
Top Sellers
| 1 | -$19.1M | |
| 2 | -$13.4M | |
| 3 | -$7.9M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$6.89M |
| 5 |
NC
Nexthera Capital
New York
|
-$5.27M |